Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell-derived neural crest cells. [PDF]
Mukae K+12 more
europepmc +1 more source
Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology [PDF]
Véronique Minard‐Colin+21 more
openalex +1 more source
PURPOSE MYCN amplification is rarely detected in patients with favorable-stage neuroblastoma (NB). To determine the clinical significance of MYCN amplification in children with favorable-stage NB, we performed a retrospective review of data from the ...
J. Schneiderman+5 more
semanticscholar +1 more source
Whereas neuroblastoma (NB) with MYCN amplification presents a poor prognosis, no single marker allows to reliably predict outcome in tumours without MYCN amplification.
G. Schleiermacher+15 more
semanticscholar +1 more source
Cascaded Weak Measurements Amplification of Ultra-small Phases [PDF]
The weak measurements based amplification of ultra-small phase was proposed in our previous work. Due to the technical imperfections, the ability of amplification is usually limited in practice. Here we introduce the concept of cascaded weak measurements amplification so that the ability of weak measurements amplification can be further improved.
arxiv
Impact of 11q Loss of Heterozygosity Status on the Response of High-Risk Neuroblastoma With MYCN Amplification to Neoadjuvant Chemotherapy. [PDF]
Lu XY+8 more
europepmc +1 more source
Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification [PDF]
Matthias Krams+5 more
openalex +1 more source
c‐Kit is preferentially expressed in MYCN‐amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI‐571 [PDF]
Roberta Vitali+8 more
openalex +1 more source
PURPOSE MYCN amplification (MNA) indicates a poor prognosis in neuroblastoma (NB) and is routinely assayed for therapy stratification. We aimed to develop a diagnostic tool to predict MYCN status using serum DNA, which, in cancer patients, predominantly ...
T. Gotoh+9 more
semanticscholar +1 more source
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma [PDF]
Qing-Rong Chen+12 more
openalex +1 more source